Cargando…

Management of Statin Intolerance in 2018: Still More Questions Than Answers

Statin therapy is generally well tolerated and very effective in the prevention and treatment of cardiovascular disease, regardless of cholesterol levels; however, it can be associated with various adverse events (myalgia, myopathy, rhabdomyolysis, and diabetes mellitus, among others). Patients freq...

Descripción completa

Detalles Bibliográficos
Autores principales: Toth, Peter P., Patti, Angelo Maria, Giglio, Rosaria Vincenza, Nikolic, Dragana, Castellino, Giuseppa, Rizzo, Manfredi, Banach, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960491/
https://www.ncbi.nlm.nih.gov/pubmed/29318532
http://dx.doi.org/10.1007/s40256-017-0259-7
_version_ 1783324589964656640
author Toth, Peter P.
Patti, Angelo Maria
Giglio, Rosaria Vincenza
Nikolic, Dragana
Castellino, Giuseppa
Rizzo, Manfredi
Banach, Maciej
author_facet Toth, Peter P.
Patti, Angelo Maria
Giglio, Rosaria Vincenza
Nikolic, Dragana
Castellino, Giuseppa
Rizzo, Manfredi
Banach, Maciej
author_sort Toth, Peter P.
collection PubMed
description Statin therapy is generally well tolerated and very effective in the prevention and treatment of cardiovascular disease, regardless of cholesterol levels; however, it can be associated with various adverse events (myalgia, myopathy, rhabdomyolysis, and diabetes mellitus, among others). Patients frequently discontinue statin therapy without medical advice because of perceived side effects and consequently increase their risk for cardiovascular events. In patients with statin intolerance, it may be advisable to change the dose, switch to a different statin, or try an alternate-day regimen. If intolerance is associated with all statins—even at the lowest dose—non-statin drugs and certain nutraceuticals can be considered. This review focuses on the definition of statin intolerance and on the development of clinical and therapeutic strategies for its management, including emerging alternative therapies.
format Online
Article
Text
id pubmed-5960491
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-59604912018-05-25 Management of Statin Intolerance in 2018: Still More Questions Than Answers Toth, Peter P. Patti, Angelo Maria Giglio, Rosaria Vincenza Nikolic, Dragana Castellino, Giuseppa Rizzo, Manfredi Banach, Maciej Am J Cardiovasc Drugs Review Article Statin therapy is generally well tolerated and very effective in the prevention and treatment of cardiovascular disease, regardless of cholesterol levels; however, it can be associated with various adverse events (myalgia, myopathy, rhabdomyolysis, and diabetes mellitus, among others). Patients frequently discontinue statin therapy without medical advice because of perceived side effects and consequently increase their risk for cardiovascular events. In patients with statin intolerance, it may be advisable to change the dose, switch to a different statin, or try an alternate-day regimen. If intolerance is associated with all statins—even at the lowest dose—non-statin drugs and certain nutraceuticals can be considered. This review focuses on the definition of statin intolerance and on the development of clinical and therapeutic strategies for its management, including emerging alternative therapies. Springer International Publishing 2018-01-09 2018 /pmc/articles/PMC5960491/ /pubmed/29318532 http://dx.doi.org/10.1007/s40256-017-0259-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Toth, Peter P.
Patti, Angelo Maria
Giglio, Rosaria Vincenza
Nikolic, Dragana
Castellino, Giuseppa
Rizzo, Manfredi
Banach, Maciej
Management of Statin Intolerance in 2018: Still More Questions Than Answers
title Management of Statin Intolerance in 2018: Still More Questions Than Answers
title_full Management of Statin Intolerance in 2018: Still More Questions Than Answers
title_fullStr Management of Statin Intolerance in 2018: Still More Questions Than Answers
title_full_unstemmed Management of Statin Intolerance in 2018: Still More Questions Than Answers
title_short Management of Statin Intolerance in 2018: Still More Questions Than Answers
title_sort management of statin intolerance in 2018: still more questions than answers
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960491/
https://www.ncbi.nlm.nih.gov/pubmed/29318532
http://dx.doi.org/10.1007/s40256-017-0259-7
work_keys_str_mv AT tothpeterp managementofstatinintolerancein2018stillmorequestionsthananswers
AT pattiangelomaria managementofstatinintolerancein2018stillmorequestionsthananswers
AT gigliorosariavincenza managementofstatinintolerancein2018stillmorequestionsthananswers
AT nikolicdragana managementofstatinintolerancein2018stillmorequestionsthananswers
AT castellinogiuseppa managementofstatinintolerancein2018stillmorequestionsthananswers
AT rizzomanfredi managementofstatinintolerancein2018stillmorequestionsthananswers
AT banachmaciej managementofstatinintolerancein2018stillmorequestionsthananswers